- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Varian to purchase GE's radiotherapy unit
Varian Associates has offered to purchase the radiotherapy service and support operation of GE Medical Systems in a deal that will cover all of the Milwaukee vendor's worldwide radiotherapy service and customer support operations. GEMS has a global
Varian Associates has offered to purchase the radiotherapy service and support operation of GE Medical Systems in a deal that will cover all of the Milwaukee vendor's worldwide radiotherapy service and customer support operations. GEMS has a global installed base of 400 linear accelerator systems and some 340 treatment planning products, according to the companies. The sale does not include GE's radiotherapy manufacturing and engineering unit located in Buc, France, which is under review, according to GEMS.
The purchase, for an undisclosed amount of cash, is expected to be completed by the end of 1997. About 160 GEMS radiotherapy service professionals, technical support personnel, and support staff will join Varian on completion of the transaction. Varian executives said that the acquisition significantly broadens the Palo Alto, CA-based company's international radiotherapy support. For GEMS, the deal allows the vendor to focus more closely on its core medical imaging, services, and information technology businesses, according to Jeffrey Immelt, president and CEO.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
